Exogenous and Endogenous Cannabinoids Control Synaptic Transmission in Mice Nucleus Accumbens

Annals of the New York Academy of Sciences

Volumn 1003, Issue , 2003, Pages 212-225

  Robbe, David ^a   Alonso, Gérard ^b   Manzoni, Olivier J ^a  

^a INSERM   (France)

^b CNRS   (France)

Author keywords

Addictive drugs; Cannabinoid CB1 receptors; GABA; Glutamate; Nucleus accumbens; Synaptic plasticity

Indexed keywords

4 AMINOBUTYRIC ACID; CALCIUM ION; CANNABINOID; CANNABINOID 1 RECEPTOR; GLUTAMATE RECEPTOR; POSTSYNAPTIC RECEPTOR; POTASSIUM CHANNEL; RYANODINE;

ANIMAL TISSUE; BRAIN; BRAIN SLICE; CALCIUM CELL LEVEL; CELL CONTACT; CONFERENCE PAPER; CONTROLLED STUDY; FEEDBACK SYSTEM; IMMUNOCYTOCHEMISTRY; INHIBITION KINETICS; LIMBIC SYSTEM; MOUSE; NERVE CELL PLASTICITY; NERVE ENDING; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRESYNAPTIC NERVE; PROTEIN EXPRESSION; SENSORY NERVE; SIGNAL TRANSDUCTION; STIMULATION; SYNAPSE; SYNAPTIC TRANSMISSION;

ANIMALIA; CANNABIS; CANNABIS SATIVA;

EID: 0347722460     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1300.013     Document Type: Conference Paper

References (38)

1. HYMAN, S.E. & R.C. MALENKA. 2001. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2: 695-703.
2. WILLIAMS, J.T., M.J. CHRISTIE & O. MANZONI. 2001. Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev. 81: 299-343.
3. NESTLER, E.J. 2001. Molecular neurobiology of addiction. Am. J. Addict. 10: 201-217.
4. NESTLER, E.J. 2002. Common molecular and cellular substrates of addiction and memory. Neurobiol. Learn. Mem. 78: 637-647.
5. SANES, J.R. & J.W. LICHTMAN. 1999. Can molecules explain long-term potentiation? Nat. Neurosci. 2: 597-604.
6. AMERI, A. 1999. The effects of cannabinoids on the brain. Prog. Neurobiol. 58: 315-348.
7. WILSON, R.I. & R.A. NICOLL. 2002. Endocannabinoid signaling in the brain. Science 296: 678-682.
8. HOFFMAN, A.F. & C.R. LUPICA. 2000. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J. Neurosci. 20: 2470-2479.
9. CHAN, P.K., S.C. CHAN & W.H. YUNG. 1998. Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonist. Neuroreport 9: 671-675.
10. LEVENES, C., H. DANIEL, P. SOUBRIE & F. CREPEL. 1998. Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells. J. Physiol. 510 (Pt 3): 867-879.
11. AUCLAIR, N., S. OTANI, P. SOUBRIE & F. CREPEL. 2000. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J. Neurophysiol. 83: 3287-3293.
12. HYMAN, S.E. 1996. Shaking out the cause of addiction. Science 273: 611-612.
13. PENNARTZ, C.M., H.J. GROENEWEGEN & F.H. LOPES DA SILVA. 1994. The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog. Neurobiol. 42: 719-761.
14. PULVIRENTI, L. & M. DIANA. 2001. Drug dependence as a disorder of neural plasticity: focus on dopamine and glutamate. Rev. Neurosci. 12: 141-158.
15. MANZONI, O., D. PUJALTE, J. WILLIAMS & J. BOCKAERT. 1998. Decreased presynaptic sensitivity to adenosine after cocaine withdrawal. J. Neurosci. 18: 7996-8002.
16. MANZONI, O., J.M. MICHEL & J. BOCKAERT. 1997. Metabotropic glutamate receptors in the rat nucleus accumbens. Eur. J. Neurosci. 9: 1514-1523.
17. MANZONI, O.J. & J.T. WILLIAMS. 1999. Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal. J. Neurosci. 19: 6629-6636.
18. TSOU, K., S. BROWN, M.C. SANUDO-PENA, K. MACKIE & J.M. WALKER. 1998. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83: 393-411.
19. ROBBE, D., G. ALONSO, F. DUCHAMP, et al. 2001. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J. Neurosci. 21: 109-116.
20. DOHERTY, J. & R. DINGLEDINE. 2003. Functional interactions between cannabinoid and metabotropic glutamate receptors in the central nervous system. Curr. Opin. Pharmacol. 3: 46-53.
21. SULLIVAN, J.M. 1999. Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. J. Neurophysiol. 82: 1286-1294.
22. HOFFMAN, A.F. & C.R. LUPICA. 2001. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J. Neurophysiol. 85: 72-83.
23. GESSA, G.L., M. MELIS, A.L. MUNTONI & M. DIANA. 1998. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur. J. Pharmacol. 341: 39-44.
24. TANDA, G., F.E. PONTIERI & G. DI CHIARA. 1997. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mul opioid receptor mechanism. Science 276: 2048-2050.
25. SZABO, B., T. MULLER & H. KOCH. 1999. Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro. J. Neurochem. 73: 1084-1089.
26. MANZONI, O.J. & J. BOCKAERT. 2001. Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens. Eur. J. Pharmacol. 412: R3-5.
27. BARTH, F. & M. RINALDI-CARMONA. 1999. The development of cannabinoid antagonists. Curr. Med. Chem. 6: 745-755.
28. KOOS, T. & J.M. TEPPER. 1999. Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nat. Neurosci. 2: 467-472.
29. KREITZER, A.C. & W.G. REGEHR. 2002. Retrograde signaling by endocannabinoids. Curr. Opin. Neurobiol. 12: 324-330.
30. CHARPIER, S., S. MAHON, & J.M. DENIAU. 1999. In vivo induction of striatal long-term potentiation by low-frequency stimulation of the cerebral cortex. Neuroscience 91: 1209-1222.
31. CARELLI, R.M. & S.G. IJAMES. 2000. Nucleus accumbens cell firing during maintenance, extinction, and reinstatement of cocaine self-administration behavior in rats. Brain Res. 866: 44-54.
32. ROBBE, D., M. KOPF, A. REMAURY, et al. 2002. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. USA 99: 8384-8388.
33. GIUFFRIDA, A. et al. 1999. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci. 2: 358-363.
34. SHIGEMOTO, R. et al. 1993. Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci. Lett. 163: 53-57.
35. PIN, J.P., C. DE COLLE, A.S. BESSIS & F. ACHER. 1999. New perspectives for the development of selective metabotropic glutamate receptor ligands. Eur. J. Pharmacol. 375: 277-294.
36. CONN, P.J. & J.P. PIN. 1997. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37: 205-237.
37. GERDEMAN, G.L., J. RONESI & D.M. LOVINGER. 2002. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci. 5: 446-451.
38. MARSICANO, G. et al. 2002. The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530-534.